CG Invites Co., Ltd. (KOSDAQ:083790)
South Korea · Delayed Price · Currency is KRW 1,120.00
+2.00 (0.18%)
May 20, 2026, 3:30 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 86.12 billion as of May 20, 2026. Its market cap has decreased by -45.23% in one year.
Market Cap
86.12B
Enterprise Value
137.03B
Revenue
27.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,120.00
Market Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 86.12B, a decrease of -37.32%. That is a compound annual growth rate of -2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 86.12B | -24.68% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 151.78B |
| MedPacto | 141.38B |
| Vaxcell-Bio Therapeutics | 137.68B |
| Amicogen | 127.03B |
| ENCell | 126.08B |
| GeneOne Life Science | 123.86B |
| iNtRON Biotechnology | 97.05B |
| Prestige BioPharma | 90.14B |